| Variable | Treatment arm | χ2 | p value | |
| Surgery (n = 20) | Surgery and adjuvant radiation therapy (n = 46) | |||
| Age category: |
|
| 0.232 | 0.630 |
| <60 years | 7 (35%) | 19 (41.3%) | ||
| ≥60 years | 13 (65%) | 27 (58.7%) | ||
| Surgery type: |
|
| 2.352 | 0.312* |
| TAH + BSO | 20 (100%) | 41 (89.1%) | ||
| Subtotal hysterectomy | 0 (0%) | 5 (10.9%) | ||
| Tumor size: |
|
| 0.428 | 0.513 |
| ≤4 cm | 10 (50%) | 27 (58.7%) | ||
| >4 cm | 10 (50%) | 19 (41.3%) | ||
| Lower uterine segment: |
|
| 0.004 | 0.947 |
| Involved | 8 (40%) | 18 (39.1%) | ||
| Not involved | 12 (60%) | 28 (60.9%) | ||
| Lymphadenectomy: |
|
| 0.497 | 0.481 |
| Done | 16 (80%) | 33 (71.74%) | ||
| Not done | 4 (20%) | 13 (28.26%) | ||
| Lymphovascular space invasion: |
|
| 4.982 | 0.097** |
| Present | 3 (15%) | 20 (43.48%) | ||
| Absent | 11 (55%) | 17 (36.96%) | ||
| Not assessed | 6 (30%) | 9 (19.56%) | ||
| Relapse: |
|
| 9.716 | 0.003* |
| Yes | 9 (45%) | 5 (10.9%) | ||
| No | 11 (55%) | 41 (89.1%) | ||